{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae Synergies plus\u2122 Gram-Positive MIC/Combo Panels with Streptomycin Synergy Screen"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K071316",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "JWY",
        "LTT"
    ],
    "Summary Letter Date": "August 20, 2007",
    "Summary Letter Received Date": "August 7, 2007",
    "Submission Date": "May 9, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short Term Incubation Cycle Antimicrobial Susceptibility Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptomycin Synergy Screen"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of gram-positive enterococci and staphylococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "WalkAway\u00ae SI System",
        "MicroScan\u00ae Instrumentation"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Fluorogenic identification",
        "Dried overnight antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Synergies plus Gram-Positive MIC/Combo Panels with Streptomycin Synergy Screen to determine antimicrobial susceptibility of enterococci and staphylococci.",
    "Indications for Use Summary": "Used to determine antimicrobial agent susceptibility of colonies of rapidly growing aerobic and facultative anaerobic gram-positive enterococci and staphylococci, with the addition of Streptomycin Synergy Screen for enterococci.",
    "fda_folder": "Microbiology"
}